基于温差发电的混合动力自行车的研究

本文主要研究了一种基于温差发电的混合动力自行车,并就其改装和发动机尾气余热利用的系统优化设计进行了集中分析,最终得出了相关结论。     

The role of inventories and capacity utilization as shock absorbers

We examine the role of inventories and capacity utilization (of both capital and labor) for the propagation of business cycle fluctuations. We document a new set of facts regarding the U.S. cyclical regularities of inventories and capacity utilization. First, we find that capital utilization and the flows of services from both capital and labor are procyclical, and comove with the holdings of inventories. Second, we find that labor utilization is procyclical as well, but is weakly negatively correlated with inventories. We build a model that accounts for these facts, and also accounts for the stylized inventory facts, i.e., inventory holdings are procyclical, while the inventory-to-sales ratio is countercyclical. The analysis is centered on the effects of two possible shocks: preference (demand) shocks and technology shocks. Our model shows that inventories and the rate of capital utilization are mostly complements, while inventories and the rate of labor utilization are mostly substitutes. It further shows that temporary demand shocks emphasize the role of inventories as being a “shock absorber,” whereas high-persistence demand shocks, as well as technology shocks of any persistence, emphasize the role of inventories as being a complement to consumption.     

Disruptive Innovation in the Nordic Countries＇ Healthcare Systems

The Nordic healtheare model is recognized to be one of the most innovative in the world. Here billions of USD are annually invested in developing new treatments, drugs, robots etc. to diagnose and cure diseases. Nevertheless, this study establishes that there is a fundamental shortcoming in the system that supports healthcare innovation： It is strongly biased towards micro-level innovation projects focusing on new products, alternative processes, and new financial solutions. The problem with this approach to support new projects is that the results are created as inventions within the system thus lacking holistic perspectives. This has consequently contributed with increasing costs that are out of proportion with existing budgets. Therefore this study seeks to analyze the current understanding of the Nordic healthcare system from a business model perspective. Here other aspects of the healthcare system are explored to determine if they could be redesigned to promote new types of innovation projects. The purpose of undertaking this task is to challenge the established patterns of the current healthcare innovation support practices. Here the vertical innovation process （VIP） framework, which is a systematic radical innovation model that seeks macro-level outcomes based on standalone inventions （see more below）, is applied to analyze the current state-of-the-art in Nordic healthcare innovation projects. The results determine that very little attention is given to rethink and redesign the healthcare system at a macro-level, and it is discussed that stand-alone inventions ought to be rethought into the entire healthcare system to create a larger impact. Finally, it is argued that existing performance measures are inappropriate to foster projects that innovate the existing system： New measuring points should be developed to promote macro-level projects and to avoid the current rapid increase of costs in the Nordic healthcare system.     

Major bleeding risk and healthcare economic outcomes of non-valvular atrial fibrillation patients newly-initiated with oral anticoagulant therapy in the real-world setting

Aims: This study compared the risk for major bleeding (MB) and healthcare economic outcomes of patients with non-valvular atrial fibrillation (NVAF) after initiating treatment with apixaban vs rivaroxaban, dabigatran, or warfarin.

Methods: NVAF patients who initiated apixaban, rivaroxaban, dabigatran, or warfarin were identified from the IMS Pharmetrics Plus database (January 1, 2013–September 30, 2015). Propensity score matching (PSM) was used to balance differences in patient characteristics between study cohorts: patients treated with apixaban vs rivaroxaban, apixaban vs dabigatran, and apixaban vs warfarin. Risk of hospitalization and healthcare costs (all-cause and MB-related) were compared between matched cohorts during the follow-up.

Results: During the follow-up, risks for all-cause (hazard ratio [HR]?=?1.44, 95% confidence interval [CI]?=?1.2–1.7) and MB-related (HR?=?1.57, 95% CI?=?1.0–2.4) hospitalizations were significantly greater for patients treated with rivaroxaban vs apixaban. Adjusted total all-cause healthcare costs were significantly lower for patients treated with apixaban vs rivaroxaban ($3,950 vs $4,333 per patient per month [PPPM], p?=?.002) and MB-related medical costs were not statistically significantly different ($100 vs $233 PPPM, p?=?.096). Risk for all-cause hospitalization (HR?=?1.98, 95% CI?=?1.6–2.4) was significantly greater for patients treated with dabigatran vs apixaban, although total all-cause healthcare costs were not statistically different. Risks for all-cause (HR?=?2.22, 95% CI?=?1.9–2.5) and MB-related (HR?=?2.05, 95% CI?=?1.4–3.0) hospitalizations were significantly greater for patients treated with warfarin vs apixaban. Total all-cause healthcare costs ($3,919 vs $4,177 PPPM, p?=?.025) and MB-related medical costs ($96 vs $212 PPPM, p?=?.026) were significantly lower for patients treated with apixaban vs warfarin.

Limitations: This retrospective database analysis does not establish causation.

Conclusions: In the real-world setting, compared with rivaroxaban and warfarin, apixaban is associated with reduced risk of hospitalization and lower healthcare costs. Compared with dabigatran, apixaban is associated with lower risk of hospitalizations.     

Participation in export and Chinese firms’ capacity utilization

This paper first sets up a firm heterogeneity trade model and shows that given capital stock and productivity, export firms will have higher rates of capacity utilization. In addition, given capital stock and fixed export costs, firms with higher productivity are more likely to export. I then use the 2012 Chinese enterprise survey from the World Bank to empirically investigate the impact of participation in export on Chinese firms’ capacity utilization rate. The results show that on average, export firms have capacity utilization rate 1.55–2.01 percent higher than non-export firms, which amounts to 14.6–18.9 percent of the standard deviation of capacity utilization rate in the sample. I also find that firms with a larger part of shares owned by the government have lower capacity utilization. Stronger market competition leads to over-investment and therefore lower capacity utilization rate. Faced with more rigorous labor market regulation, firms will substitute capital for the use of labor, resulting in higher capacity utilization rate.     

A Social Marketing Template for Solving the Musicians’ Dilemma Through Nonprofit Healthcare Networks

The Musicians’ Dilemma—the lack of affordable healthcare for the uninsured or underinsured musical entrepreneur—is actually a common problem plaguing not only 33% of musicians, but approximately 19% of the American population as a whole. The current research uses social marketing principles to conceptualize a template for designing a marketing program that meets the healthcare needs of the target market. Health Alliance for Austin Musicians (HAAM) is a nonprofit organization that links healthcare providers, local businesses, and community donors in a network providing basic preventive health services to this essential segment of the community. HAAM's business model is analyzed and cast on the social marketing framework so that it can be adapted for use by other music cities. Although the template could also be applied to serve other uninsured populations, it is critical that research be undertaken to understand the specific characteristics and needs of each target market and used to adapt the model to those populations.     

浅析民办院校图书馆发展中个性化信息服务建立的问题和策略——以陕西国际商贸学院步长图书馆为例

做好信息服务,有效的利用图书馆文献资源,发挥图书馆职能,是当下形势所趋。本文通过对陕西省民办高校——陕西国际商贸学院图书馆的信息服务的现状和存在的问题做一分析,针对这一类院校图书馆特点,提出了优化信息服务的策略。     

社会医疗保险对老人临终医疗服务利用的影响

本文利用2002-2014年CLHLS死亡人口数据,借助样本选择模型、两部分模型和bootstrap中介效应检验方法,首次比较全面深入地分析了社会医疗保险对老人临终总医疗费用支出和自负医疗费用支出的影响。研究发现,我国社会医疗保险既显著提高了老人临终医疗服务利用,也显著降低了自负水平。不同类型的社会医疗保险对临终医疗服务利用影响存在差异,医疗保险类型对临终医疗服务利用具有直接效应,医疗保险水平发挥了中介作用。医疗保险覆盖率在死亡年份影响临终医疗服务利用中发挥了中介作用。我国应该通过实行健康老龄化战略、加强死亡教育、发展临终关怀和完善医保监管等措施控制临终医疗支出增长以促进医疗保险可持续发展,并提升临终老人生存和死亡质量。     

我国农作物秸秆资源化利用的经济分析:一个理论框架

农作物秸秆是生物质资源的主要来源之一,与之相关的技术开发目前已成为生态农业和可持续发展的一个重大课题。农作物秸秆资源化利用有肥料、燃料、饲料、工业原料和食用菌基料等多种途径和技术路径,这些利用方式和技术的经济可行性如何,引起了研究者越来越多的关注。文章提供了一个对我国农作物秸秆资源化利用行为进行经济分析的理论框架。在该框架中,农作物秸秆资源化利用的总收益包括秸秆产品的市场价值、秸秆资源使用节约的相关资源性产品价值以及秸秆产品使用产生的环境收益;农作物秸秆资源化利用的总成本则由秸秆的收集、运输、储藏、加工以及机会成本构成。最后,文章对农作物秸秆资源化利用的公共政策等问题进行讨论。     

清洁发展机制下黑龙江省生物质能利用分析

清洁发展机制可以为生物质能的利用提供资金帮助和技术支持,文章结合黑龙江省生物质能利用及生物质清洁发展机制项目现状,分析了清洁发展机制下黑龙江省利用生物质能的优势、劣势、机会及威胁,并提出了CDM机制下促进黑龙江省生物质能利用的对策。